Close
Nordic 9Nordic 9

Pivotal bioVenture Partners (investor - Venture Capital)

United States pivotalbiovp.com
See something wrong or missing? Let us know
Offices:San Francisco

Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017 and investing in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs.

Average round investment:68.5M USD
Average number per year:1.0
Distribution: 2025 (1)2021 (1)
Portfolio companies: Switzerland Mosanna TherapeuticsIceland Oculis Pharma
Mostly invests in: Switzerland Switzerland (1) Biotech (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Pivotal bioVenture Partners

Name Criteria
United Kingdom Abingworth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States 5AM Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Perceptive Life
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Northleaf Capital Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States venBio Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States Surveyor Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland Korify Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Foresite Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland BioMedPartners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Top